{"id":"https://openalex.org/W2188129664","doi":null,"title":"IMMUNO-ENDOCRINE DISTURBANCES IN ALZHEIMER DEMENTIA","display_name":"IMMUNO-ENDOCRINE DISTURBANCES IN ALZHEIMER DEMENTIA","publication_year":2011,"publication_date":"2011-01-01","ids":{"openalex":"https://openalex.org/W2188129664","mag":"2188129664"},"language":"en","primary_location":{"id":"mag:2188129664","doi":null,"is_oa":false,"landing_page_url":"https://www.researchgate.net/profile/Liana_Dehelean/publication/263767053_Immuno-Endocrine_Disturbances_in_Alzheimer_Dementia/links/548817d40cf2ef34478eeb66.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5102839773","display_name":"Liana Dehelean","orcid":"https://orcid.org/0000-0003-1160-8575","observed_orcids":["https://orcid.org/0000-0003-1160-8575"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Liana Dehelean","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-1160-8575","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003267053","display_name":"Elena Stefan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Elena D Stefan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5071323658","display_name":"C.C. Vasilian","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C.C. Vasilian","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.9761000275611877,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.9761000275611877,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":0.02160000056028366,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11266","display_name":"Neuroinflammation and Neurodegeneration Mechanisms","score":0.001500000013038516,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.9729999899864197},{"id":"https://openalex.org/keywords/immunological-factors","display_name":"immunological factors","score":0.5419999957084656},{"id":"https://openalex.org/keywords/hormonal-factors","display_name":"hormonal factors","score":0.984000027179718},{"id":"https://openalex.org/keywords/somatostatin","display_name":"somatostatin","score":0.7979999780654907},{"id":"https://openalex.org/keywords/insulin","display_name":"insulin","score":0.9610000252723694},{"id":"https://openalex.org/keywords/thyroid-hormones","display_name":"thyroid hormones","score":0.7310000061988831},{"id":"https://openalex.org/keywords/gsk-3beta","display_name":"GSK3\u03b2","score":0.7820000052452087},{"id":"https://openalex.org/keywords/amyloid-beta","display_name":"amyloid-beta","score":0.7770000100135803},{"id":"https://openalex.org/keywords/insulin-degrading-enzyme","display_name":"insulin-degrading enzyme","score":0.9110000133514404},{"id":"https://openalex.org/keywords/neprilysin","display_name":"neprilysin","score":0.9980000257492065},{"id":"https://openalex.org/keywords/subclinical-hypothyroidism","display_name":"subclinical hypothyroidism","score":0.8180000185966492},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.843999981880188},{"id":"https://openalex.org/keywords/autoimmune-factors","display_name":"autoimmune factors","score":0.5049999952316284},{"id":"https://openalex.org/keywords/cytokines","display_name":"cytokines","score":0.800000011920929},{"id":"https://openalex.org/keywords/tau-protein","display_name":"tau protein","score":0.6679999828338623},{"id":"https://openalex.org/keywords/cognitive-decline","display_name":"cognitive decline","score":0.4300000071525574}],"concepts":[{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.5758323669433594},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.5706869959831238},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.5600390434265137},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5435305833816528},{"id":"https://openalex.org/C2780331951","wikidata":"https://www.wikidata.org/wiki/Q1225690","display_name":"Insulin-degrading enzyme","level":3,"score":0.5429508686065674},{"id":"https://openalex.org/C2776297358","wikidata":"https://www.wikidata.org/wiki/Q407166","display_name":"Somatostatin","level":2,"score":0.51612389087677},{"id":"https://openalex.org/C46699223","wikidata":"https://www.wikidata.org/wiki/Q11078","display_name":"Endocrine system","level":3,"score":0.49472305178642273},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.4520735740661621},{"id":"https://openalex.org/C2779483572","wikidata":"https://www.wikidata.org/wiki/Q83030","display_name":"Dementia","level":3,"score":0.44746196269989014},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.42202886939048767},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3339076042175293},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.20492756366729736}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2188129664","doi":null,"is_oa":false,"landing_page_url":"https://www.researchgate.net/profile/Liana_Dehelean/publication/263767053_Immuno-Endocrine_Disturbances_in_Alzheimer_Dementia/links/548817d40cf2ef34478eeb66.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9763000011444092}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":33,"referenced_works":["https://openalex.org/W1606512690","https://openalex.org/W1967564647","https://openalex.org/W1968053343","https://openalex.org/W1970779072","https://openalex.org/W1971222486","https://openalex.org/W1978180139","https://openalex.org/W1986646769","https://openalex.org/W2002363989","https://openalex.org/W2005481412","https://openalex.org/W2018923984","https://openalex.org/W2019711233","https://openalex.org/W2024438481","https://openalex.org/W2024977010","https://openalex.org/W2027667432","https://openalex.org/W2028403300","https://openalex.org/W2028942501","https://openalex.org/W2032515982","https://openalex.org/W2040550914","https://openalex.org/W2055845981","https://openalex.org/W2063620211","https://openalex.org/W2070064344","https://openalex.org/W2072652145","https://openalex.org/W2075226611","https://openalex.org/W2080232093","https://openalex.org/W2098957321","https://openalex.org/W2127549277","https://openalex.org/W2129699049","https://openalex.org/W2136731379","https://openalex.org/W2140741951","https://openalex.org/W2143545218","https://openalex.org/W2168769697","https://openalex.org/W2386517867","https://openalex.org/W2418319663"],"related_works":["https://openalex.org/W2015381052","https://openalex.org/W2051437126","https://openalex.org/W2068411486","https://openalex.org/W3181155299","https://openalex.org/W2907509362","https://openalex.org/W2046463428","https://openalex.org/W390675772","https://openalex.org/W2024977010","https://openalex.org/W1532185247","https://openalex.org/W982825565"],"abstract_inverted_index":{"Introduction:":[0],"Alzheimer":[1],"Dementia":[2],"(AD)":[3],"is":[4,105,236],"a":[5,9,194,244],"primary":[6],"dementia":[7],"with":[8,64,208,212,218],"complex":[10,31,148],"pathogeny.":[11],"Genetic,":[12],"endocrine,":[13],"immunological":[14,37],"and":[15,36,53,60,74,88,91,93,97,110,121,143,154,185,199,220,233,241,252],"environmental":[16],"factors":[17,38,62],"contribute":[18],"in":[19,43,71,85,94,247],"various":[20],"degrees":[21],"to":[22,117,238],"cognitive":[23,98,231],"deterioration.":[24],"Objectives:":[25],"The":[26,55,77],"present":[27],"paper":[28],"summarizes":[29],"the":[30,44,159,230,248,256],"interactions":[32],"between":[33,58,151],"genetic,":[34],"endocrine":[35,61],"that":[39,82,113,163,196],"may":[40,49,204,228,254],"be":[41,205,239,255],"involved":[42,84],"development":[45],"of":[46,192,250],"AD,":[47],"or":[48,177,211],"aggravate":[50],"it.":[51],"Material":[52],"Method:":[54],"possible":[56,245],"links":[57],"immunologic":[59],"associated":[63,207],"AD":[65,186,203,253],"were":[66],"collected":[67],"from":[68],"data":[69],"published":[70],"psychiatry,":[72],"immunology":[73],"endocrinology":[75],"journals.":[76],"research":[78],"focused":[79],"on":[80],"hormones":[81,109,153],"are":[83,147,178],"cell":[86,95],"metabolism":[87,96],"growth":[89],"(insulin":[90],"somatostatin)":[92],"functioning":[99],"(thyroid":[100],"hormones).":[101],"Results:":[102],"Neuronal":[103],"activity":[104],"influenced":[106],"by":[107,180],"neurotransmitters,":[108,152],"cytokines":[111],"(interleukins)":[112],"use":[114],"secondary":[115],"messengers":[116],"influence":[118],"enzymes":[119],"(GSK-3\u00e2)":[120],"gene":[122],"transcription":[123],"factors.":[124],"Through":[125],"protein":[126],"phosphorylation,":[127],"GSK-3\u00e2":[128],"controls":[129],"synaptic":[130,135],"transmission":[131,140],"(voltage-dependent":[132],"calcium":[133],"channels),":[134],"structure":[136],"(\u00e2":[137],"catenin),":[138],"intra-axonal":[139],"(protein":[141],"tau),":[142],"neuronal":[144],"metabolism.":[145],"There":[146],"reciprocal":[149],"relationships":[150],"cytokines.":[155],"Amyloid":[156],"\u00e2":[157],"stimulates":[158],"immune":[160],"response.":[161],"Enzymes":[162],"reduce":[164],"amyloid":[165],"\u00e242":[166],"levels":[167,191],"(IDE":[168],"/":[169],"insulindegrading":[170],"enzyme,":[171],"neprilysin)":[172],"also":[173],"catabolize":[174],"insulin":[175,198,219,222],"(IDE),":[176],"stimulated":[179],"somatostatin":[181],"(neprilysin).":[182],"Aging":[183],"people":[184],"patients":[187],"have":[188],"low":[189],"brain":[190],"somatostatin,":[193],"hormone":[195],"regulates":[197],"TSH":[200],"secretion.":[201],"Conclusion:":[202],"independently":[206],"overt":[209],"autoimmune":[210],"subclinical":[213],"hypothyroidism,":[214],"as":[215,217],"well":[216],"non":[221],"dependent":[223],"diabetes":[224,251],"mellitus.":[225],"These":[226],"conditions":[227],"enhance":[229],"deterioration":[232],"therefore,":[234],"it":[235],"important":[237],"identified":[240],"corrected.":[242],"Also,":[243],"target":[246],"treatment":[249],"enzyme":[257],"GSK-3\u00e2,":[258],"using":[259],"GSK-3":[260],"inhibitors.":[261]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}